Combining radiotherapy with MEK1/2, STAT5 or STAT6 inhibition reduces survival of head and neck cancer lines

Table 1 Characteristics of UT-SCC cell lines

Cell line	TNM*	Primary tumor location	Type of lesion	Grade	SF4 ± SEM
UT-SCC5	T₁N₁M₀	Tongue	Primary	2	0.42 ± 0.03
UT-SCC8	T₂N₀M₀	Supraglottic larynx	Primary	1	0.22 ± 0.02
UT-SCC15	T₁N₀M₀	Tongue	Recurrence	1	0.31 ± 0.02
UT-SCC19A	T₄N₀M₀	Glottic larynx	Primary	2	0.19 ± 0.02
UT-SCC24A	T₂N₀M₀	Tongue	Primary	2	0.40 ± 0.02
UT-SCC29	T₂N₀M₀	Glottic larynx	Primary	1	0.23 ± 0.01
UT-SCC38	T₂N₀M₀	Glottic larynx	Primary	2	0.23 ± 0.03
UT-SCC40	T₃N₀M₀	Tongue	Primary	1	0.33 ± 0.02
UT-SCC45	T₃N₁M₀	Floor of mouth	Primary	3	0.28 ± 0.03

*TNM status of primary tumors according to the International Union against Cancer (1997).
Note: Grade: 1, well differentiated; 2, moderately differentiated; 3, poorly differentiated.
SF4, Surviving fraction after 4 Gy; SEM, Standard error of the mean.

ISSN: 1476-4598